{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:05:53Z","timestamp":1773252353006,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adverse events and mortality tend to cluster around dialysis sessions, potentially due to the impact of the saw-toothed profile of uraemic toxins such as potassium, peaking pre-dialysis and rapidly dropping during dialysis. Acidosis could be contributing to this harm by exacerbating a rise in potassium. The objectives of this study were to investigate the effects of oral bicarbonate treatment on reducing inter-dialytic potassium gain as well as other clinical consequences of preserving muscle mass and function and reducing intradialytic arrhythmia risk in people on haemodialysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Open-label randomised controlled trial in a single-centre (London, UK). Forty-three clinically stable adults on haemodialysis were recruited, with a 6\u2009month average pre-dialysis serum bicarbonate level\u2009&lt;\u200922\u2009mmol\/l and potassium &gt;\u20094\u2009mmol\/l. Thirty-three participants completed the study. Oral sodium bicarbonate tablets titrated up to a maximum of 3\u2009g bd (6\u2009g total) in intervention group for 12\u2009weeks versus no treatment in the control group. Outcomes compared intervention versus non-intervention phases in the treated group and equivalent time points in the control group: pre- and post-dialysis serum potassium; nutritional assessments: muscle mass and handgrip strength and electrocardiograms (ECGs) pre and post dialysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Participants took an average of 3.7\u2009\u00b1\u20090.5\u2009g sodium bicarbonate a day. In the intervention group, inter-dialytic potassium gain was reduced from 1.90\u2009\u00b1\u20090.60 to 1.69\u2009\u00b1\u20090.49\u2009mmol\/l (<jats:italic>p<\/jats:italic>\u00a0=\u20090.032) and pre-dialysis potassium was reduced from 4.96\u00a0\u00b1\u20090.62 to 4.79\u00a0\u00b1\u20090.49\u2009mmol\/l without dietary change. Pre-dialysis bicarbonate increased from 18.15\u00a0\u00b1\u20091.35 to 20.27\u00a0\u00b1\u20091.88\u2009mmol\/l, however with an increase in blood pressure. Nutritionally, lean tissue mass was reduced in the controls suggesting less catabolism in the intervention group. There was no change in ECGs. Limitations are small sample size and unblinded study design lacking a placebo, with several participants failing to achieve the target of 22\u2009mmol\/l serum bicarbonate levels due mainly to tablet burden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Oral sodium bicarbonate reduced bicarbonate loss and potassium gain in the inter-dialytic period, and may also preserve lean tissue mass.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study was registered prospectively on 06\/08\/2015 with EU Clinical Trials Register EudraCT number <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2015-001439-20\">2015-001439-20<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02549-x","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T08:03:13Z","timestamp":1634803393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Oral sodium bicarbonate in people on haemodialysis: a randomised controlled trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Stella I.","family":"Kourtellidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien R.","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina R.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"issue":"4","key":"2549_CR1","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1046\/j.1523-1755.1999.00391.x","volume":"55","author":"AJ Bleyer","year":"1999","unstructured":"Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int. 1999;55(4):1553\u20139. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00391.x.","journal-title":"Kidney Int"},{"key":"2549_CR2","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1038\/sj.ki.5000446","volume":"69","author":"AJ Bleyer","year":"2006","unstructured":"Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int. 2006;69:2268\u201373. https:\/\/doi.org\/10.1038\/sj.ki.5000446.","journal-title":"Kidney Int"},{"key":"2549_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000045387","volume":"82","author":"A Cupisti","year":"1999","unstructured":"Cupisti A, Galetta F, Caprioli R, et al. Potassium removal increases the QTc interval dispersion during hemodialysis. Nephron. 1999;82:122\u20136. https:\/\/doi.org\/10.1159\/000045387.","journal-title":"Nephron."},{"key":"2549_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2215\/CJN.04451206","volume":"2","author":"CP Kovesdy","year":"2007","unstructured":"Kovesdy CP, Regidor DL, Mehrotra R, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol. 2007;2:999\u20131007. https:\/\/doi.org\/10.2215\/CJN.04451206.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2549_CR5","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/ndt\/gfp104","volume":"24","author":"S Genovesi","year":"2009","unstructured":"Genovesi S, Valsecchi MG, Rossi E, et al. Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24:2529\u201336. https:\/\/doi.org\/10.1093\/ndt\/gfp104.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2549_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.ajkd.2016.10.024","volume":"70","author":"SM Brunelli","year":"2017","unstructured":"Brunelli SM, Du Mond C, Oestreicher N, Rakov V, Spiegel DM. Serum potassium and short-term clinical outcomes among hemodialysis patients: impact of the long Interdialytic interval. Am J Kidney Dis. 2017;70(1):21\u20139. https:\/\/doi.org\/10.1053\/j.ajkd.2016.10.024.","journal-title":"Am J Kidney Dis"},{"key":"2549_CR7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1053\/j.ajkd.2004.06.008","volume":"44","author":"J Bommer","year":"2004","unstructured":"Bommer J, Locatelli F, Satayathum S, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2004;44:661\u201371. https:\/\/doi.org\/10.1053\/j.ajkd.2004.06.008.","journal-title":"Am J Kidney Dis"},{"key":"2549_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2215\/CJN.00010505","volume":"1","author":"DY Wu","year":"2006","unstructured":"Wu DY, Shinaberger CS, Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K. Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic? Clin J Am Soc Nephrol. 2006;1:70\u20138. https:\/\/doi.org\/10.2215\/CJN.00010505.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2549_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ndt\/gfh661","volume":"20","author":"RM Heguil\u00e9n","year":"2005","unstructured":"Heguil\u00e9n RM, Sciurano C, Bellusci AD, et al. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients. Nephrol Dial Transplant. 2005;20:591\u20137. https:\/\/doi.org\/10.1093\/ndt\/gfh661.","journal-title":"Nephrol Dial Transplant"},{"key":"2549_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1681\/ASN.V84632","volume":"8","author":"KA Graham","year":"1997","unstructured":"Graham KA, Reaich D, Channon M, Downie S, Goodship THJ. Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol. 1997;8:632\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"2549_CR11","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1152\/ajpendo.2002.282.1.e107","volume":"282","author":"TA Ikizler","year":"2002","unstructured":"Ikizler TA, Pupim LB, Brouillette JR, et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Metab. 2002;282:E107\u201316. https:\/\/doi.org\/10.1152\/ajpendo.2002.282.1.e107.","journal-title":"Am J Physiol Metab"},{"issue":"1","key":"2549_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.ajkd.2010.12.021","volume":"58","author":"MK Abramowitz","year":"2011","unstructured":"Abramowitz MK, Hostetter TH, Melamed ML. Association of serum bicarbonate levels with gait speed and quadriceps strength in older adults. Am J Kidney Dis. 2011;58(1):29\u201338. https:\/\/doi.org\/10.1053\/j.ajkd.2010.12.021.","journal-title":"Am J Kidney Dis"},{"key":"2549_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2215\/CJN.08340812","volume":"8","author":"MK Abramowitz","year":"2013","unstructured":"Abramowitz MK, Melamed ML, Bauer C, Raff AC, Hostetter TH. Effects of oral sodium bicarbonate in patients with CKD. Clin J Am Soc Nephrol. 2013;8:714\u201320. https:\/\/doi.org\/10.2215\/CJN.08340812.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2549_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1051-2276(03)00092-X","volume":"13","author":"D Blair","year":"2003","unstructured":"Blair D, Bigelow C, Sweet SJ. Nutritional effects of delivered bicarbonate dose in maintenance hemodialysis patients. J Ren Nutr. 2003;13(3):205\u201311. https:\/\/doi.org\/10.1016\/S1051-2276(03)00092-X.","journal-title":"J Ren Nutr"},{"key":"2549_CR15","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1681\/ASN.V3111804","volume":"3","author":"CWO","year":"1993","unstructured":"CWO, JCO. Normalization of uremic acidosis in hemodialysis patients with a high bicarbonate dialysate. J Am Soc Nephrol. 1993;3:1804\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"2549_CR16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/sdi.12716","volume":"31","author":"C Basile","year":"2018","unstructured":"Basile C, Rossi L, Lomonte C. Dialysate bicarbonate concentration: too much of a good thing? Semin Dial. 2018;31:576\u201382. https:\/\/doi.org\/10.1111\/sdi.12716.","journal-title":"Semin Dial"},{"issue":"10","key":"2549_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/oxfordjournals.ndt.a092299","volume":"8","author":"G Enia","year":"1993","unstructured":"Enia G, Sicuso C, Alati G, Zoccali C, Pustorino D, Biondo A. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant. 1993;8(10):1094\u20138. https:\/\/doi.org\/10.1093\/oxfordjournals.ndt.a092299.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2549_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2215\/CJN.08850811","volume":"7","author":"M Jadoul","year":"2012","unstructured":"Jadoul M, Thumma J, Fuller DS, et al. Modifiable practices associated with sudden death among hemodialysis patients in the dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol. 2012;7(5):765\u201374. https:\/\/doi.org\/10.2215\/CJN.08850811.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2549_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0272-6386(99)70077-6","volume":"34","author":"J Uribarri","year":"1999","unstructured":"Uribarri J, Levin NW, Delmez J, et al. Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis. 1999;34(3):493\u20139. https:\/\/doi.org\/10.1016\/S0272-6386(99)70077-6.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2549_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/j.jrn.2008.08.012","volume":"19","author":"E Movilli","year":"2009","unstructured":"Movilli E, Viola BF, Camerini C, Mazzola G, Cancarini GC. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients. J Ren Nutr. 2009;19(2):172\u20137. https:\/\/doi.org\/10.1053\/j.jrn.2008.08.012.","journal-title":"J Ren Nutr"},{"key":"2549_CR21","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1097\/01.ASN.0000080316.37254.7A","volume":"14","author":"CC Szeto","year":"2003","unstructured":"Szeto CC, Wong TYH, Chow KM, Leung CB, Li PKT. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J Am Soc Nephrol. 2003;14:2119\u201326. https:\/\/doi.org\/10.1097\/01.ASN.0000080316.37254.7A.","journal-title":"J Am Soc Nephrol"},{"key":"2549_CR22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jama.281.14.1275","volume":"281","author":"KL Johansen","year":"1999","unstructured":"Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. J Am Med Assoc. 1999;281:1275\u201381. https:\/\/doi.org\/10.1001\/jama.281.14.1275.","journal-title":"J Am Med Assoc"},{"issue":"9","key":"2549_CR23","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1681\/asn.2008111205","volume":"20","author":"I de Brito-Ashurst","year":"2009","unstructured":"de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075\u201384. https:\/\/doi.org\/10.1681\/asn.2008111205.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2549_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000504557","volume":"51","author":"P Kittiskulnam","year":"2020","unstructured":"Kittiskulnam P, Srijaruneruang S, Chulakadabba A, et al. Impact of serum bicarbonate levels on muscle mass and kidney function in pre-Dialysis chronic kidney disease patients. Am J Nephrol. 2020;51(1):24\u201334. https:\/\/doi.org\/10.1159\/000504557.","journal-title":"Am J Nephrol"},{"key":"2549_CR25","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2215\/CJN.05480614","volume":"9","author":"R Yenchek","year":"2014","unstructured":"Yenchek R, Ix JH, Rifkin DE, et al. Association of serum bicarbonate with incident functional limitation in older adults. Clin J Am Soc Nephrol. 2014;9:2111\u20136. https:\/\/doi.org\/10.2215\/CJN.05480614.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2549_CR26","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2215\/cjn.13091118","volume":"14","author":"SD Navaneethan","year":"2019","unstructured":"Navaneethan SD, Shao J, Buysse J, Bushinsky DA. Effects of treatment of metabolic acidosis in CKD. Clin J Am Soc Nephrol. 2019;14:1011\u201320. https:\/\/doi.org\/10.2215\/cjn.13091118.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2549_CR27","doi-asserted-by":"publisher","unstructured":"Witham MD, Band M, Chong H, et al. Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: The BiCARB RCT. Health Technol Assess (Rockv). 2020;24(27). https:\/\/doi.org\/10.3310\/hta24270.","DOI":"10.3310\/hta24270"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02549-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T08:06:03Z","timestamp":1634803563000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02549-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2549"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02549-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"2 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the West London & GTAC Research Ethics Committee (15\/LO\/1011) and was performed in accordance with the Declaration of Helsinki, with written informed consent from participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DA has received a speaker\u2019s honorarium from Fibrogen.SK and LJ declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}